Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Barcos

Showing results (81-90 of 94) with videos related to

Pageof 10
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2001
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251E J Lee, G R Petroni, C A Schiffer, et al.
Cancer|November 1, 1990
A randomized comparison of methotrexate dose and the addition of bleomycin to CHOP therapy for diffuse large cell lymphoma and other non-Hodgkin's lymphomas. Cancer and Leukemia Group B study 7851A J Gottlieb, J R Anderson, S J Ginsberg, et al.
Blood|July 1, 1983
Malignant lymphoma, mixed cell type, diffuseB N Nathwani, G E Metter, R A Gams, et al.
The New England Journal of Medicine|May 5, 1994
c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancerH B Muss, A D Thor, D A Berry, et al.
Medical and Pediatric Oncology|January 1, 1994
Combination trial of subcutaneous recombinant alpha 2 b interferon and oral cyclophosphamide in follicular low-grade non-Hodgkin's lymphomaH Ozer, J R Anderson, B A Peterson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2000
HER-2/neu and p53 expression versus tamoxifen resistance in estrogen receptor-positive, node-positive breast cancerD A Berry, H B Muss, A D Thor, et al.
Cancer Research|January 15, 1994
Molecular rearrangement of the ALL-1 gene in acute myeloid leukemia without cytogenetic evidence of 11q23 chromosomal translocationsM A Caligiuri, S A Schichman, M P Strout, et al.
Diabetes|July 30, 2002
Cerivastatin improves insulin sensitivity and insulin secretion in early-state obese type 2 diabetesJ A Paniagua, J López-Miranda, A Escribano, et al.
Journal of the National Cancer Institute|September 25, 1998
erbB-2, p53, and efficacy of adjuvant therapy in lymph node-positive breast cancerA D Thor, D A Berry, D R Budman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1985
Morphological subclassification of follicular lymphoma: variability of diagnoses among hematopathologists, a collaborative study between the Repository Center and Pathology Panel for Lymphoma Clinical StudiesG E Metter, B N Nathwani, J S Burke, et al.
Pageof 10

Showing results (81-90 of 94) with videos related to

Sort By:
Pageof 10
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2001
Brief-duration high-intensity chemotherapy for patients with small noncleaved-cell lymphoma or FAB L3 acute lymphocytic leukemia: results of cancer and leukemia group B study 9251E J Lee, G R Petroni, C A Schiffer, et al.
Cancer|November 1, 1990
A randomized comparison of methotrexate dose and the addition of bleomycin to CHOP therapy for diffuse large cell lymphoma and other non-Hodgkin's lymphomas. Cancer and Leukemia Group B study 7851A J Gottlieb, J R Anderson, S J Ginsberg, et al.
Blood|July 1, 1983
Malignant lymphoma, mixed cell type, diffuseB N Nathwani, G E Metter, R A Gams, et al.
The New England Journal of Medicine|May 5, 1994
c-erbB-2 expression and response to adjuvant therapy in women with node-positive early breast cancerH B Muss, A D Thor, D A Berry, et al.
Medical and Pediatric Oncology|January 1, 1994
Combination trial of subcutaneous recombinant alpha 2 b interferon and oral cyclophosphamide in follicular low-grade non-Hodgkin's lymphomaH Ozer, J R Anderson, B A Peterson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2000
HER-2/neu and p53 expression versus tamoxifen resistance in estrogen receptor-positive, node-positive breast cancerD A Berry, H B Muss, A D Thor, et al.
Cancer Research|January 15, 1994
Molecular rearrangement of the ALL-1 gene in acute myeloid leukemia without cytogenetic evidence of 11q23 chromosomal translocationsM A Caligiuri, S A Schichman, M P Strout, et al.
Diabetes|July 30, 2002
Cerivastatin improves insulin sensitivity and insulin secretion in early-state obese type 2 diabetesJ A Paniagua, J López-Miranda, A Escribano, et al.
Journal of the National Cancer Institute|September 25, 1998
erbB-2, p53, and efficacy of adjuvant therapy in lymph node-positive breast cancerA D Thor, D A Berry, D R Budman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1985
Morphological subclassification of follicular lymphoma: variability of diagnoses among hematopathologists, a collaborative study between the Repository Center and Pathology Panel for Lymphoma Clinical StudiesG E Metter, B N Nathwani, J S Burke, et al.
Pageof 10